相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module
Karl-Heinz Klempnauer
EXPERIMENTAL HEMATOLOGY (2022)
Natural withanolides, an update
Gui-Yang Xia et al.
NATURAL PRODUCT REPORTS (2022)
A synthetic covalent ligand of the C/EBPβ transactivation domain inhibits acute myeloid leukemia cells
Daria Frank et al.
CANCER LETTERS (2022)
MYB oncoproteins: emerging players and potential therapeutic targets in human cancer
Ylenia Ciciro et al.
ONCOGENESIS (2021)
C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia
Maria V. Yusenko et al.
ONCOGENE (2021)
Comparative reactivity analysis of small-molecule thiol surrogates
Laszlo Petri et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Helenalin - A Sesquiterpene Lactone with Multidirectional Activity
Joanna Drogosz et al.
CURRENT DRUG TARGETS (2019)
PRISMA: Protein Interaction Screen on Peptide Matrix Reveals Interaction Footprints and Modifications-Dependent Interactome of Intrinsically Disordered C/EBPβ
Gunnar Dittmar et al.
ISCIENCE (2019)
Overview on Anticancer Drug Design and Development
Sureyya Olgen
CURRENT MEDICINAL CHEMISTRY (2018)
The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression
Anna Coulibaly et al.
PLOS ONE (2018)
Recent Advances on Cytotoxic Sesquiterpene Lactones
Jose Quintana et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Naphthoquinones: A continuing source for discovery of therapeutic antineoplastic agents
Han-Yue Qiu et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2018)
Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia
Sunniyat Rahman et al.
BLOOD (2017)
Withaferin A, a natural compound with anti-tumor activity, is a potent inhibitor of transcription factor C/EBPβ
Kim D. Falkenberg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction
Sagar Uttarkar et al.
BLOOD (2016)
Helenalin Acetate, a Natural Sesquiterpene Lactone with Anti-inflammatory and Anti-cancer Activity, Disrupts the Cooperation of CCAAT Box/Enhancer-binding Protein β (C/EBPβ) and Co-activator p300
Anke Jakobs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
C/EBPβ regulates homeostatic and oncogenic gastric cell proliferation
Goncalo Regalo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
An isoform-specific C/EBPβ inhibitor targets acute myeloid leukemia cells
A. Jakobs et al.
LEUKEMIA (2016)
Small-Molecule Disruption of the Myb/p300 Cooperation Targets Acute Myeloid Leukemia Cells
Sagar Uttarkar et al.
MOLECULAR CANCER THERAPEUTICS (2016)
An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma
Yotam Drier et al.
NATURE GENETICS (2016)
MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism
Pratiti Bandopadhayay et al.
NATURE GENETICS (2016)
BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia
Jae-Seok Roe et al.
MOLECULAR CELL (2015)
CCAAT/Enhancer binding protein β induces motility and invasion of glioblastoma cells through transcriptional regulation of the calcium binding protein S100A4
Diana Aguilar-Morante et al.
ONCOTARGET (2015)
Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes
Diwakar R. Pattabiraman et al.
BLOOD (2014)
Polypharmacology: Challenges and Opportunities in Drug Discovery
Andrew Anighoro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
Marc R. Mansour et al.
SCIENCE (2014)
Structural insights into interactions of C/EBP transcriptional activators with the Taz2 domain of p300
Prasenjit Bhaumik et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2014)
Natural sesquiterpene lactones as inhibitors of Myb-dependent gene expression: Structure-activity relationships
Caroline Schomburg et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Interaction and Cooperation of the CCAAT-box Enhancer-binding Protein β (C/EBPβ) with the Homeodomain-interacting Protein Kinase 2 (Hipk2)
Simone Steinmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
Jinghui Zhang et al.
NATURE GENETICS (2013)
Regulation of C/EBPβ and resulting functions in cells of the monocytic lineage
Rene Huber et al.
CELLULAR SIGNALLING (2012)
Application of the Hard and Soft, Acids and Bases (HSAB) Theory to Toxicant-Target Interactions
Richard M. LoPachin et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Inhibition of Myb-dependent gene expression by the sesquiterpene lactone mexicanin-I
T. Bujnicki et al.
LEUKEMIA (2012)
Perspectives on Sesquiterpene Lactones in Inflammation and Cancer
Irmgard Merfort
CURRENT DRUG TARGETS (2011)
An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance
Johannes Zuber et al.
GENES & DEVELOPMENT (2011)
Natural withanolides: an overview
Li-Xia Chen et al.
NATURAL PRODUCT REPORTS (2011)
Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb
Liang Zhao et al.
NUCLEIC ACIDS RESEARCH (2011)
Celastrol: Molecular targets of Thunder God Vine
Antero Salminen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Crosstalk between C/EBPβ phosphorylation, arginine methylation, and SWI/SNF/Mediator implies an indexing transcription factor code
Elisabeth Kowenz-Leutz et al.
EMBO JOURNAL (2010)
C/EBPβ expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway
Natasa Anastasov et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Thiol-yne click chemistry: A powerful and versatile methodology for materials synthesis
Andrew B. Lowe et al.
JOURNAL OF MATERIALS CHEMISTRY (2010)
The transcriptional network for mesenchymal transformation of brain tumours
Maria Stella Carro et al.
NATURE (2010)
Hierarchical Maintenance of MLL Myeloid Leukemia Stem Cells Employs a Transcriptional Program Shared with Embryonic Rather Than Adult Stem Cells
Tim C. P. Somervaille et al.
CELL STEM CELL (2009)
Inhibition of Lysine Acetyltransferase KAT3B/p300 Activity by a Naturally Occurring Hydroxynaphthoquinone, Plumbagin
Kodihalli C. Ravindra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck
Marta Persson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
C/EBPβ Regulates Metastatic Gene Expression and Confers TNF-α Resistance to Prostate Cancer Cells
Myoung H. Kim et al.
PROSTATE (2009)
C/EBPs: recipients of extracellular signals through proteome modulation
Claus Nerlov
CURRENT OPINION IN CELL BIOLOGY (2008)
G9a-mediated lysine methylation alters the function of CCAAT/enhancer-binding protein-β
Ole Pless et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
C/EBPβ induces chromatin opening at a cell-type-specific enhancer
Annette Plachetka et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Acetylation and deacetylation regulate CCAAT/enhancer binding protein β at K39 in mediating gene transcription
Teresa I. Cesena et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
MYB function in normal and cancer cells
Robert G. Ramsay et al.
NATURE REVIEWS CANCER (2008)
Alu elements mediate MYB gene tandem duplication in human T-ALL
Jennifer O'Neil et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells
Yvette Drabsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children
Emmanuelle Clappier et al.
BLOOD (2007)
The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control
Claus Nerlov
TRENDS IN CELL BIOLOGY (2007)
Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia
Idoya Lahortiga et al.
NATURE GENETICS (2007)
c-Myb is required for progenitor cell homeostasis in colonic crypts
Jordane Malaterre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Functional validation of the analplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes
Roberto Piva et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Mutations in the MYB intron I regulatory sequence increase transcription in colon cancers
Honor Hugo et al.
GENES CHROMOSOMES & CANCER (2006)
c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells
Jay L. Hess et al.
BLOOD (2006)
Stop and go -: Anti-proliferative and mitogenic functions of the transcription factor C/EBPβ
Thomas Sebastian et al.
CELL CYCLE (2006)
c-Myb is critical for B cell development and maintenance of follicular B cells
MD Thomas et al.
IMMUNITY (2005)
c-Myb and p300 regulate stem cell proliferation an hematopoietic differentiation
ML Sandberg et al.
DEVELOPMENTAL CELL (2005)
v-Myb mediates cooperation of a cell-specific enhancer with the mim-1 promoter
O Chayka et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Suppressor screen in Mpl-/- mice:: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling
MR Carpinelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb
T Zor et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Transcriptional regulation of the cyclooxygenase-2 gene in macrophages by PU.1
M Joo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Critical functions for c-Myb at three checkpoints during thymocyte development
TP Bender et al.
NATURE IMMUNOLOGY (2004)
Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb
N Emambokus et al.
EMBO JOURNAL (2003)
Modification of CCAAT/enhancer-binding protein-β by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3
EM Eaton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Distinct changes in gene expression induced by A-Myb, B-Myb and c-Myb proteins
JJ Rushton et al.
ONCOGENE (2003)
A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis
LH Kasper et al.
NATURE (2002)
Cysteine 38 in p65/NF-κB plays a crucial role in DNA binding inhibition by sesquiterpene lactones
AJ García-Piñeres et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer -: Clinical and experimental findings
A Biroccio et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Tumor necrosis factor alpha inhibits type I collagen synthesis through repressive CCAAT/enhancer-binding proteins
P Greenwel et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
